In summary, despite the important role ascribed to Lewy bodies in DLB, there is relatively little evidence that they are associated with the neurodegeneration and impairment that is thought to underlie clinical manifestation and progression, perhaps suggesting oligomers or other α-synuclein conformers could be more centrally involved in driving DLB. This evidence concerns the gene SNCA and Lewy body dementia.